A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

被引：0
|
作者：
Sun, Weili [1 ]
Gaynon, Paul S. [2 ]
Sposto, Richard [2 ]
Bittencourt, Henrique [3 ]
Place, Andrew E. [4 ]
Messinger, Yoav H. [5 ]
Fraser, Chris [6 ]
Dalla-Pozza, Luciano [7 ]
van der Giessen, Jeannette [2 ]
Eckroth, Elena [2 ]
Yang, Xiaojing [8 ]
Liang, Gangning [8 ]
Jones, Peter A. [8 ,9 ]
Wayne, Alan S. [1 ]
Cooper, Todd [10 ,11 ]
机构：
[1] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA
[2] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[3] Univ Montreal, St Justine Univ Hosp, Montreal, PQ, Canada
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA
[6] Royal Childrens Hosp, Brisbane, Qld, Australia
[7] Childrens Hosp Westmead, Sydney, NSW, Austria
[8] Univ So Calif, Los Angeles, CA USA
[9] Van Andel Res Inst, Grand Rapids, MI USA
[10] Emory Univ, Aflac Canc Ctr, Atlanta, GA 30322 USA
[11] Emory Univ, Blood Disorders Serv, Atlanta, GA 30322 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Phase I Study of AC220 in Combination with Cytarabine and Etoposide in Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
    Cooper, Todd
    Sposto, Richard
    Cassar, Jeannette
    Eckroth, Elena
    Malvar, Jemily
    Gaynon, Paul
    Dubois, Steven
    Chang, Bill H.
    Gore, Lia
    August, Keith J.
    Thomson, Blythe
    Gammon, Guy
    Magoon, Daniel
    Annesley, Colleen E.
    Brown, Patrick
    BLOOD, 2012, 120 (21)
  • [2] A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study
    Cooper, Todd Michael
    Malvar, Jemily
    Cassar, Jeannette
    Eckroth, Elena
    Sposto, Richard
    Gaynon, Paul
    Dubois, Steven
    Gore, Lia
    Macy, Margaret E.
    August, Keith J.
    Thomson, Blythe
    Oesterheld, Javier
    Gammon, Guy
    Magoon, Daniel
    Annesley, Colleen E.
    Brown, Patrick
    BLOOD, 2013, 122 (21)
  • [3] A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
    Cooper, Todd M.
    Cassar, Jeannette
    Eckroth, Elena
    Malvar, Jemily
    Sposto, Richard
    Gaynon, Paul
    Chang, Bill H.
    Gore, Lia
    August, Keith
    Pollard, Jessica A.
    DuBois, Steven G.
    Silverman, Lewis B.
    Oesterheld, Javier
    Gammon, Guy
    Magoon, Daniel
    Annesley, Colleen
    Brown, Patrick A.
    CLINICAL CANCER RESEARCH, 2016, 22 (16) : 4014 - 4022
  • [4] A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium
    Sun, Weili
    Triche, Timothy, Jr.
    Malvar, Jemily
    Gaynon, Paul
    Sposto, Richard
    Yang, Xiaojing
    Bittencourt, Henrique
    Place, Andrew E.
    Messinger, Yoav
    Fraser, Chris
    Dalla-Pozza, Luciano
    Salhia, Bodour
    Jones, Peter
    Wayne, Alan S.
    Gore, Lia
    Cooper, Todd M.
    Liang, Gangning
    BLOOD, 2018, 131 (10) : 1145 - 1148
  • [5] Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
    Pommert, Lauren
    Bhojwani, Deepa
    Sposto, Richard
    Florendo, Ellynore
    Schafer, Eric
    Gossai, Nathan
    Van Thu Huynh
    Rao, Sridhar
    Burke, Michael J.
    BLOOD, 2019, 134
  • [6] Outcome for Children Treated for Relapsed or Refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study
    Gorman, Matthew F.
    Ji, Lingyun
    Ko, Richard H.
    Barnette, Phillip
    Bostrom, Bruce
    Hutchinson, Raymond
    Raetz, Elizabeth
    Seibel, Nita L.
    Twist, Clare J.
    Eckroth, Elena
    Sposto, Richard
    Gaynon, Paul S.
    Loh, Mignon L.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (03) : 421 - 429
  • [7] Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting
    Wayne, Alan S.
    Shin-Kashiyama, Erika
    Sposto, Richard
    Gaynon, Paul
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (6-7) : 349 - 354
  • [8] Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
    Verma, Anupam
    Chi, Yueh-Yun
    Malvar, Jemily
    Lamble, Adam
    Chaudhury, Sonali
    Agarwal, Archana
    Li, Hong-Tao
    Liang, Gangning
    Leong, Roy
    Brown, Patrick A.
    Kaplan, Joel
    Schafer, Eric S.
    Slone, Tamra
    Pauly, Melinda
    Chang, Bill H.
    Stieglitz, Elliot
    Wayne, Alan S.
    Hijiya, Nobuko
    Bhojwani, Deepa
    CANCERS, 2024, 16 (03)
  • [9] Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
    Messinger, Yoav H.
    Gaynon, Paul S.
    Sposto, Richard
    van der Giessen, Jeannette
    Eckroth, Elena
    Malvar, Jemily
    Bostrom, Bruce C.
    BLOOD, 2012, 120 (02) : 285 - 290
  • [10] Phase I Study of Bortezomib Combined With Chemotherapy in Children With Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leukemia (TACL) Consortium
    Messinger, Yoav
    Gaynon, Paul
    Raetz, Elizabeth
    Hutchinson, Raymond
    DuBois, Steven
    Glade-Bender, Julia
    Sposto, Richard
    van der Giessen, Jeannette
    Eckroth, Elena
    Bostrom, Bruce C.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 254 - 259
12345